Sheng Xu

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 12

Top Topics

Natural Killer Cells

Top Venues

Cell death & disease

Signal transduction and targeted therapy

Cellular & molecular immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Chenglong Zhu, Sheng Xu, Ruoyu Jiang, Yizhi Yu, Jinjun Bian, Zui Zou
The gasdermin family: emerging therapeutic targets in diseases. Signal transduction and targeted therapy 9 (1) (2024)
Jie Chen, Likun Cui, Shaoteng Lu, Sheng Xu
Amino acid metabolism in tumor biology and therapy. Cell death & disease 15 (1) (2024)
Chenglong Zhu, Sheng Xu, Ruoyu Jiang, Yizhi Yu, Jinjun Bian, Zui Zou
The gasdermin family: emerging therapeutic targets in diseases. Signal transduction and targeted therapy 9 (1) (2024)
Jie Chen, Likun Cui, Shaoteng Lu, Sheng Xu
Amino acid metabolism in tumor biology and therapy. Cell death & disease 15 (1) (2024)
Jie Chen, Likun Cui, Shaoteng Lu, Sheng Xu
Amino acid metabolism in tumor biology and therapy. Cell death & disease 15 (1) (2024)
DanRu Wang, LingYun Dou, LiHao Sui, Yiquan Xue, Sheng Xu
Natural killer cells in cancer immunotherapy. MedComm 5 (7) (2024)
Yunkai Zhang, Ying Gao, Yujia Wang, Yuyu Jiang, Yan Xiang, Xiaohui Wang, Zeting Wang, Yingying Ding, Huiying Chen, Bing Rui, Wanwan Huai, Boyu Cai, Xiaomeng Ren, Feng Ma, Sheng Xu, Zhenzhen Zhan, Xingguang Liu
RBM25 is required to restrain inflammation via ACLY RNA splicing-dependent metabolism rewiring. Cellular & molecular immunology (2024)
DanRu Wang, LingYun Dou, LiHao Sui, Yiquan Xue, Sheng Xu
Natural killer cells in cancer immunotherapy. MedComm 5 (7) (2024)
Jie Chen, Likun Cui, Shaoteng Lu, Sheng Xu
Amino acid metabolism in tumor biology and therapy. Cell death & disease 15 (1) (2024)
Chenglong Zhu, Sheng Xu, Ruoyu Jiang, Yizhi Yu, Jinjun Bian, Zui Zou
The gasdermin family: emerging therapeutic targets in diseases. Signal transduction and targeted therapy 9 (1) (2024)
Yijie Tao, Shulei Yin, Yang Liu, Chunzhen Li, Yining Chen, Dan Han, Jingyi Huang, Sheng Xu, Zui Zou, Yizhi Yu
UFL1 promotes antiviral immune response by maintaining STING stability independent of UFMylation. Cell death and differentiation (2022)
Simo Xia, Yijie Tao, Likun Cui, Yizhi Yu, Sheng Xu
MHC Class I Molecules Exacerbate Viral Infection by Disrupting Type I Interferon Signaling. Journal of immunology research 2019 (2019)